Sarepta surges after FDA panel backs Duchenne gene therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. PSKY
3. META
4. LGND
5. SPY
6. MONC:IM
7. PTON
8. NYXH
9. LXEO
10. MONRY

Go back to Sarepta surges after FDA panel backs Duchenne gene therapy
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 20.56 +0.42 (2.09%)
Previous Close $20.14    52 Week High $63.73 
Open $20.46    52 Week Low $8.00 
Day High $20.57    P/E N/A 
Day Low $20.19    EPS $-5.69 
Volume 115,200